Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | SGMT Sagimet Biosciences Inc. - Series A | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $9.88 +5.9% | $16.31 +6.3% |
| StockIQ Score | 52C- Moderate Risk: High | 42D Weak Risk: Medium |
| Technical | 50C- | 36F |
| Fundamental | 46D+ | 35F |
| Growth | 38F | 50C- |
| Fair Value | 50C- | 38F |
| News | 98A+ | 50C- |
| Quality | — | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
SGMT outperforms AAPG in investor confidence, technicals, and fundamentals, with scores of 52, 50, and 46 respectively, compared to AAPG’s 42, 36, and 35. However, AAPG leads in growth and valuation, scoring 50 and 38, while SGMT’s growth is lower at 38. SGMT’s overall rating is moderate, stronger than AAPG’s weak rating.
